Primary undifferentiated pleomorphic cardiac sarcoma with MDM2 amplification presenting as acute left-sided heart failure.
Richard L WatsonJoseph FryeMegan TrieuMichael X YangPublished in: BMJ case reports (2018)
Primary cardiac tumours are a rare clinical entity that can present with myriad of non-specific cardiopulmonary symptoms. We describe a case of a 61-year-old previously healthy woman who presented with progressive dyspnoea and lower extremity swelling, suggestive of acute left-sided heart failure. Transthoracic echocardiogram revealed a large, 3.7×3.2 cm intracardiac mass resulting in severe mitral valvular dysfunction. The patient underwent surgical resection of the mass, however, negative margins were not obtained, and the tumour quickly returned. Histological and molecular analysis was consistent with the diagnosis of undifferentiated pleomorphic sarcoma with murine double minute 2 (MDM2) amplification. Given the overall grim prognosis, the patient chose to pursue comfort-based care. She died at home 9 months after the initial diagnosis. Here, we provide an updated review of the literature for the classification of undifferentiated pleomorphic cardiac sarcoma and potential treatment modalities.
Keyphrases
- left ventricular
- heart failure
- liver failure
- case report
- atrial fibrillation
- drug induced
- healthcare
- respiratory failure
- cardiac resynchronization therapy
- multiple sclerosis
- machine learning
- mitral valve
- aortic dissection
- nucleic acid
- palliative care
- oxidative stress
- left atrial
- deep learning
- hepatitis b virus
- quality improvement
- coronary artery disease
- aortic valve
- acute heart failure
- aortic stenosis
- intensive care unit
- affordable care act
- depressive symptoms
- transcatheter aortic valve replacement
- chronic pain
- human health